true

Phasix™ ST Mesh

Fully Bioresorbable Scaffold Featuring Proven Sepra^® Technology

Overview
Products & Accessories
EIFU & Resources
Reimbursement

Designed for a strong repair enables functional tissue remodeling

Phasix™ ST Mesh combines two market-leading technologies into one product: monofilament resorbable Phasix™ Mesh and a proven hydrogel barrier based on Sepra® technology. While the monofilament mesh supports functional healing and a strong repair, the hydrogel barrier minimizes tissue attachment to the visceral side of the mesh for intraabdominal placement.¹

These meshes are available in different shapes, such as round, rectangle, and square.

For high-risk/comorbid patients, surgeons have had to choose between permanent synthetic meshes and biologic grafts—and their inherent pros and cons. Synthetic meshes can have complications that lead to mesh removal or reoperation, while biologic grafts can have accelerated degradation in the presence of bacteria which may lead to mesh failure.

Phasix™ ST Mesh handles, sutures and fixates like a synthetic mesh, while exhibiting the remodeling characteristics of a biologic mesh. It facilitates trocar deployment during laparoscopic placement.

The ST hydrogel barrier

Minimizes risk of tissue attachment
Has over 10 years of clinical application
Resorbs in 30 days
15 clinical studies

The Phasix™ ST Mesh is a biologically derived scaffold with a hydrogel barrier for intraabdominal placement. It has been designed to provide the repair strength of a synthetic mesh and the remodeling characteristics of a biologic.

The Phasix™ ST Mesh does the following:

Handles, sutures and fixates like a synthetic mesh
Facilitates trocar deployment during laparoscopic placement
Its longitudinal stripes aid with orientation and visibility during placement

true

Surgical Education Events

MATERIAL STRUCTURE¹

Monofilament mesh designs have been shown more biocompatible and less susceptible to bacterial adherence and colonization.

REPAIRS HERNIAS¹

The open monofilament mesh structure provides early integration and repair strength.¹

REMODELS ISSUES OVER TIME¹

Vascular integration and incorporation continues, with abundant mature collagen at 52 weeks. Gradually transfers load to native tissue over time.¹

VERSATILE TECGNIQUES¹

Phasix™ ST Mesh may be placed in either an intraabdominal or preperitoneal position after primary hernia defect closure. Primary hernia defect closure should be achieved prior to placing the mesh.

HERNIA DEFECT CLOSURE

Hernia defect closure can be achieved through an open or minimally invasive approach (i.e., laparoscopic, robotic). Recent studies suggest potential advantages of defect closure include:

• Decreased “dead” space, which can reduce the risk of postoperative seromas

• May contribute to restoration of a functional abdominal wall

• May reduce postoperative bulging at the hernia defect site

PROMISING RESULTS IN THE PRESENCE OF BACTERIA

Phasix™ ST Mesh has not been shown to break down in the presence of bacteria—maintaining 100% of its strength at 56 days —unlike biologic grafts which demonstrate accelerated degradation in the presence of bacteria.

As shown in the graphic below, there was no presence of bacterial colonization observed in Phasix Mesh™ or Phasix™ ST Mesh 7 days post-inoculation in preclinical testing. The other side of this graph shows the presence of abscess (white material) observed SurgiMend® , Strattice™, Bio - A®, and OviTex™. Other observed indications of bacterial colonization included swelling, presence of fluids, and thickened capsule tissue.

false

BD-76012

The BD Phasix™ Reimbursement Hotline is available to answer your questions.

Learn More

false

The BD Phasix™ Reimbursement Hotline is available to answer your questions.

The hotline can be reached via phone or email.

(800)614-7965 | reimbursementsupport@bd.com

Any email or voice mail will be returned within 48 business hours. For information on physician billing, please contact your respective professional society.

true